According to the average expression of SATB1 of 52 AML patients, patients were then categorized into SATB1high and SATB1low, of which the CR rate was 76.47% and 56.14%, respectively (P = 0.1891, Table 1). The gene discussed is SATB1; the disease is acute myeloid leukemia.